ScinoPharm Taiwan Ltd Financial Flexibility Index
ScinoPharm Taiwan Ltd financial flexibility index. ScinoPharm Taiwan Ltd (1789) has a Financial Flexibility Index of 0.18x as of March 2026. Free cash flow of NT$282.80 Million (operating CF NT$199.47 Million minus capex NT$83.34 Million) represents 0% of total liabilities (NT$1.55 Billion). Explore 1789 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ScinoPharm Taiwan Ltd (2007–2025)
Financial flexibility index of ScinoPharm Taiwan Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for ScinoPharm Taiwan Ltd across 19 annual periods. Check ScinoPharm Taiwan Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ScinoPharm Taiwan Ltd Financial Flexibility Index by Year (2007–2025)
ScinoPharm Taiwan Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for ScinoPharm Taiwan Ltd. For the full cash flow conversion analysis, see 1789 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | NT$888.40 Million | NT$597.11 Million | NT$1.33 Billion | ▼ -9.2% |
| 2024 | 0.73x | NT$1.04 Billion | NT$750.91 Million | NT$1.42 Billion | ▲ +93.0% |
| 2023 | 0.38x | NT$515.84 Million | NT$231.13 Million | NT$1.36 Billion | ▼ -45.8% |
| 2022 | 0.70x | NT$1.02 Billion | NT$773.79 Million | NT$1.46 Billion | ▼ -0.5% |
| 2021 | 0.70x | NT$831.14 Million | NT$509.82 Million | NT$1.18 Billion | ▼ -17.9% |
| 2020 | 0.86x | NT$1.13 Billion | NT$946.31 Million | NT$1.32 Billion | ▲ +35.6% |
| 2019 | 0.63x | NT$894.64 Million | NT$788.95 Million | NT$1.41 Billion | ▼ -5.8% |
| 2018 | 0.67x | NT$1.36 Billion | NT$1.23 Billion | NT$2.02 Billion | ▲ +10.9% |
| 2017 | 0.61x | NT$1.38 Billion | NT$971.71 Million | NT$2.28 Billion | ▼ -27.2% |
| 2016 | 0.83x | NT$2.12 Billion | NT$1.67 Billion | NT$2.56 Billion | ▲ +14.8% |
| 2015 | 0.72x | NT$1.71 Billion | NT$1.04 Billion | NT$2.36 Billion | ▼ -24.6% |
| 2014 | 0.96x | NT$1.91 Billion | NT$888.29 Million | NT$1.99 Billion | ▼ -19.1% |
| 2013 | 1.19x | NT$2.18 Billion | NT$939.47 Million | NT$1.84 Billion | ▼ -19.2% |
| 2012 | 1.47x | NT$1.86 Billion | NT$981.55 Million | NT$1.27 Billion | ▼ -35.8% |
| 2011 | 2.29x | NT$2.10 Billion | NT$1.29 Billion | NT$920.78 Million | ▼ -28.0% |
| 2010 | 3.17x | NT$1.97 Billion | NT$1.56 Billion | NT$620.97 Million | ▲ +188.0% |
| 2009 | 1.10x | NT$1.49 Billion | NT$1.30 Billion | NT$1.35 Billion | ▲ +64.7% |
| 2008 | 0.67x | NT$1.55 Billion | NT$1.41 Billion | NT$2.32 Billion | ▲ +253.3% |
| 2007 | 0.19x | NT$587.24 Million | NT$504.50 Million | NT$3.10 Billion | — |